An investigation of combined SCLC and NSCLC demonstrated that the inactivation of TP53/RB1 function is related to the histogenesis of de novo combined SCLC/NSCLC and pulmonary adenocarcinoma with SCLC transformation after EGFR-TKI treatment. The gene discussed is RB1; the disease is non-small cell lung carcinoma.